Welldoc is Expanding – The Patent Data Can Tell Us Where
Welldoc is a healthcare company that develops solutions for managing chronic diseases. Its chronic care management platform uses AI to track and implement healthcare plans tailored to specific conditions such as diabetes, heart failure,…
Should Apple be eyeing AliveCor?
On September 21st, 2018, Apple released the Series 4, the first smartwatch with a built-in sensor capable of taking an accurate electrocardiogram (ECG). Now onto the 5th series of watches, Apple still produces the only smartwatch capable…
AliveCor Continues to Light Up
AliveCor has been in the news recently for its efforts to support front line personnel during the COVID-19 crisis. Since receiving FDA clearance for its KardiaMobile 6L personal ECG within the last year, the company must be thinking about…
Microsoft Eyes Eyes
Microsoft, the global software and technology giant, has dabbled in the AI-Biotech sector over the last few years, specifically with filings related to the cardiovascular system and activity tracking. Now, we are seeing something…
uBiome preventing heart disease with antimicrobial
uBiome, located in San Francisco CA, is administering a therapeutically effective amount of a compound for inhibiting CutC and/or CntA enzymes associated with microorganisms. CutC and CntA enzymes are associated with cardiovascular and…
IBM commits $50 million to research; teams with Broad Institute
IBM Watson Health will make a 10-year, $50 million investment in research collaborations and teamed up with Broad Institute to predict risks of cardiovascular disease.
Patent Forecast® gives you AI-driven, interactive data that identifies key innovators and first movers.
